Robert Rogers, MD
Interventional Cardiology · Aurora, CONPI 1952506107
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Medtronic at 32.9% of the total. Reporting peaked in 2019 at $162 and has fallen 90.4% since, to $16 in 2025. That places this record below the midpoint for interventional cardiology clinicians in CO, where the typical reported total is $6,820.
Across 11 payments — averaging $32.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$118
- Abiomed$103
- Philips North America LLC$71
- Cardiovascular Systems Inc.$39
- Stryker$16
- Regeneron Healthcare Solutions, Inc.$11
Across 16 payments — averaging $13,990 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$221K
- Philips North America LLC$2K
What the payments were for
- Food & beverage$358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 3 | $118 |
| Abiomed | 1 | $103 |
| Philips North America LLC | 1 | $71 |
| Cardiovascular Systems Inc. | 4 | $39 |
| Stryker | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$103
How this compares
$358 in reported general payments places this provider in the 5th percentile of 111 interventional cardiology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $44,619 |
| XareltoRivaroxaban | 12 | $13,346 |
| Ezetimibe | 30 | $1,167 |
| Rosuvastatin Calcium | 26 | $690 |
| Atorvastatin Calcium | 46 | $516 |
| Metoprolol Succinate | 35 | $499 |
| Losartan Potassium | 29 | $273 |
| Spironolactone | 20 | $245 |
| Amlodipine Besylate | 26 | $238 |
| Metoprolol Tartrate | 12 | $190 |
| ClopidogrelClopidogrel Bisulfate | 29 | $186 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Aurora
- Gareth MorganAurora$536K
- Jamaluddin MolooAurora$272K
- Jenny Zablah AlabiAurora$269K
- Sridhar Sampath-KumarAurora$142K
- Matthew ZipseAurora$137K
- Jeffrey ParkAurora$132K
- Akhil Rasim ReddyAurora$29K
- John CarrollAurora$25K
- Connie HessAurora$19K
- Aken DesaiAurora$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.